Results 21 - 30 of 32 : Previous 1 2 3 4 Next
The pharmaceutical gets an advisory panel hearing on its lead drug.
Progenics and partner Wyeth announce plans to start three new clinical trials.
It takes another run at getting FDA approval for its lead drug.
Watch These Four Drug Developers
A look at four drugmakers that deserve to be on any investor's watch list.
Progenics Gets Back In the Game
Progenics reports positive study results.
Go hunting for misunderstood multibaggers in the making.
Progenics' marketing application for its lead compound gets accepted for review.
Progenics' Intriguing Study Results
Progenics releases clinical trial results for one of its compound.
Big news is in the offing for these companies.
Adolor announces dour clinical trial results.
Legal Information © 1995 - 2008 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK